Posted by Shane Hupp on Jan 15th, 2025
JPMorgan Chase & Co. reduced its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 21.5% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 255,144 shares of the medical device...
More of this article »